| Name: | Atorvastatin Epoxy Tetrahydrofuran Analog |
| Catalogue No. | VL10030 |
| CAS No. | 873950-19-7 |
| Molecular Formula | C₂₆H₂₄FNO₅ |
| Molecular Weight | 449.47 |
| Status | In-stock |
| IUPAC Name | 4-(4-Fluorophenyl)-2,4-dihydroxy-2-isopropyl-N,5-diphenyl-3,6-dioxabicyclo[3.1.0]hexane-1-carboxamid |
| Synonyms | Atorvastatin Epoxy Dihydroxy |
| Appearance | White Solid |
| Description | Atorvastatin epoxy tetrahydrofuran analog (CAS No: 873950-19-7) or 4-(4-Fluorophenyl)-2,4-dihydroxy-2-isopropyl-N,5-diphenyl-3,6-dioxabicyclo[3.1.0]hexane-1-carboxamide is an impurity of atorvastatin. it is used for the treatment of For patients with coronary heart disease, atorvastatin has approval as a therapy to reduce the risk of non-fatal myocardial infarction, fatal and non-fatal stroke, revascularization procedures, hospitalizations for congestive heart failure, and angina. |
| References | McIver, Lindsey A., and Momin S. Siddique. “Atorvastatin.” Nih.gov, StatPearls Publishing, 5 Jan. 2019, www.ncbi.nlm.nih.gov/books/NBK430779/. Black, Donald M., et al. “An Overview of the Clinical Safety Profile of Atorvastatin (Lipitor), a New HMG-CoA Reductase Inhibitor.” Archives of Internal Medicine, vol. 158, no. 6, Mar. 1998, p. 577, https://doi.org/10.1001/archinte.158.6.577. |
